1. Home
  2. SOFI vs VTRS Comparison

SOFI vs VTRS Comparison

Compare SOFI & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SoFi Technologies Inc.

SOFI

SoFi Technologies Inc.

HOLD

Current Price

$17.09

Market Cap

22.2B

Sector

Finance

ML Signal

HOLD

Logo Viatris Inc.

VTRS

Viatris Inc.

HOLD

Current Price

$17.01

Market Cap

18.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOFI
VTRS
Founded
2011
1961
Country
United States
United States
Employees
N/A
30000
Industry
Diversified Financial Services
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.2B
18.7B
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
SOFI
VTRS
Price
$17.09
$17.01
Analyst Decision
Buy
Buy
Analyst Count
16
4
Target Price
$24.43
$13.50
AVG Volume (30 Days)
82.7M
9.1M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
3.21%
EPS Growth
N/A
N/A
EPS
0.12
0.15
Revenue
$619,353,000.00
$14,299,900,000.00
Revenue This Year
$32.54
$4.41
Revenue Next Year
$21.82
$1.96
P/E Ratio
$147.17
$117.63
Revenue Growth
23.10
N/A
52 Week Low
$14.92
$8.63
52 Week High
$32.73
$17.68

Technical Indicators

Market Signals
Indicator
SOFI
VTRS
Relative Strength Index (RSI) 45.53 56.13
Support Level $16.84 $15.82
Resistance Level $19.18 $17.17
Average True Range (ATR) 0.90 0.51
MACD -0.16 0.07
Stochastic Oscillator 19.11 62.32

Price Performance

Historical Comparison
SOFI
VTRS

About SOFI SoFi Technologies Inc.

SoFi is a financial-services company that was founded in 2011 and is based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020, the company also offers payment and account services for debit cards and digital banking.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: